Ulrich Mengs

Title: Ulrich Mengs: Innovator in Hepatitis Treatment

Introduction

Ulrich Mengs is a notable inventor based in Roesrath, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of viral hepatitis. With a total of 2 patents, his work focuses on innovative solutions for liver diseases.

Latest Patents

Mengs' latest patents include a silibinin component for the treatment of hepatitis and a method for preparing amorphous silibinin. The first patent relates to the use of a silibinin component for producing a medicament designed for parenteral administration to treat viral hepatitis, specifically hepatitis B or C. This medicament is notable for its formulation, which preferably excludes silidianin, silichristin, and isosilibinin. The second patent details a method for preparing amorphous silibinin derived from milk thistle fruit extract. This formulation boasts an increased release rate and improved bioavailability, making it suitable for treating or preventing liver diseases, particularly in patients undergoing liver transplantation.

Career Highlights

Throughout his career, Mengs has worked with reputable companies such as Madaus GmbH and Euromed S.A. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Mengs has collaborated with notable professionals in his field, including Lucio C. Rovati and Ralf-Torsten Pohl. These collaborations have further enhanced his research and development efforts.

Conclusion

Ulrich Mengs stands out as an influential inventor in the medical field, particularly for his advancements in hepatitis treatment. His innovative patents and collaborations reflect his commitment to improving patient care and outcomes.